(CHRS) Coherus Biosciences BollingerBands charts technical analysis
(CHRS) Coherus Biosciences BollingerBands charts technical analysis BollingerBands analysis of Coherus Biosciences | Buy/Sell Coherus Biosciences
Coherus Biosciences trades in USA in Health Care sector.
10 day averaged volume of Coherus Biosciences is 1465510
| Date | Closing Price | Open | High | Low | Volume |
| 01 Wed May 2024 | 2.06 | 1.97 | 2.15 | 1.96 | 1.386 Mn |
| 30 Tue Apr 2024 | 1.96 | 2.05 | 2.09 | 1.96 | 1.381 Mn |
| 29 Mon Apr 2024 | 2.07 | 2.04 | 2.14 | 2.04 | 0.901 Mn |
| 26 Fri Apr 2024 | 2.04 | 1.96 | 2.06 | 1.93 | 0.907 Mn |
| 25 Thu Apr 2024 | 1.93 | 2.03 | 2.03 | 1.91 | 2.22 Mn |
| 24 Wed Apr 2024 | 2.02 | 2.19 | 2.21 | 2.02 | 0.88 Mn |
| 23 Tue Apr 2024 | 2.18 | 2.14 | 2.25 | 2.10 | 0.812 Mn |
| 22 Mon Apr 2024 | 2.18 | 2.07 | 2.19 | 2.04 | 1.5 Mn |
| 19 Fri Apr 2024 | 2.07 | 2.02 | 2.09 | 1.95 | 2.88 Mn |
| 18 Thu Apr 2024 | 2.00 | 2.15 | 2.19 | 1.99 | 1.918 Mn |
Indicators analysis of Coherus Biosciences (CHRS)
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Coherus Biosciences in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Coherus Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Coherus Biosciences in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Coherus Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.04 and Coherus Biosciences (CHRS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences (CHRS) stock. Volume based technical analysis of Coherus Biosciences (CHRS) stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
BollingerBands charts
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Coherus Biosciences in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Coherus Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Coherus Biosciences in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Coherus Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.04 and Coherus Biosciences (CHRS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences (CHRS) stock. Volume based technical analysis of Coherus Biosciences (CHRS) stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.